Daily tailored radiation may spare prostate cancer patients from harsh side effects
NCT ID NCT06547398
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new type of radiation therapy for prostate cancer that adjusts the treatment each day based on changes in the patient's anatomy. The goal is to see if this adaptive approach can safely reduce side effects like bladder and bowel problems. The trial involves 130 men and has two phases: first checking if the new workflow is practical, then testing if smaller radiation margins can lower toxicity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Adaptive radiotherapy (radiation therapy that adjusts daily to changes in anatomy)
What this could lead to
If successful, this approach could reduce side effects like urinary and bowel problems for men receiving radiation for prostate cancer.
What could go wrong
This is an early feasibility study with only 130 participants, so results may not apply widely. The technology is new and may not be practical in all clinics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northern Sydney Cancer Centre, Royal North Shore Hospital
RECRUITINGSt Leonards, New South Wales, 2065, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact